Galen Wright
Galen Wright
Assistant Professor, Department of Pharmacology & Therapeutics, University of Manitoba
Verified email at umanitoba.ca - Homepage
Title
Cited by
Cited by
Year
Huntington disease
NS Caron, GEB Wright, MR Hayden
GeneReviews®[Internet], 2020
962020
Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation
L Warnich, B I Drogemoller, M S Pepper, C Dandara, G EB Wright
Current Pharmacogenomics and Personalized Medicine 9 (3), 191-207, 2011
752011
Nuclear receptor NR1H3 in familial multiple sclerosis
Z Wang, AD Sadovnick, AL Traboulsee, JP Ross, CQ Bernales, ...
Neuron 90 (5), 948-954, 2016
712016
Ethical and legal implications of whole genome and whole exome sequencing in African populations
GEB Wright, PGJ Koornhof, AA Adeyemo, N Tiffin
BMC Medical Ethics 14 (1), 21, 2013
582013
Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population
GEB Wright, DJH Niehaus, BI Drögemöller, L Koen, A Gaedigk, L Warnich
Annals of Human Genetics 74 (4), 340-350, 2010
542010
Characterization of the genetic profile of CYP2C19 in two South African populations
BI Drögemöller, GEB Wright, DJH Niehaus, L Koen, S Malan, DM Da Silva, ...
Pharmacogenomics 11 (8), 1095-1103, 2010
512010
Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease
GEB Wright, JA Collins, C Kay, C McDonald, E Dolzhenko, Q Xia, ...
The American Journal of Human Genetics 104 (6), 1116-1126, 2019
472019
The global spectrum of protein-coding pharmacogenomic diversity
GEB Wright, B Carleton, MR Hayden, CJD Ross
The Pharmacogenomics Journal 18, 187–195, 2018
472018
Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study
TM Dodgen, WE Hochfeld, H Fickl, SM Asfaha, C Durandt, P Rheeder, ...
BMC Medical Genetics 14 (1), 20, 2013
422013
Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer
BI Drögemöller, JG Monzon, AP Bhavsar, AE Borrie, B Brooks, ...
JAMA Oncology 3 (11), 1558-1562, 2017
352017
Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment
BI Drögemöller, GEB Wright, DJH Niehaus, R Emsley, L Warnich
Pharmacogenetics and Genomics 23 (12), 666-674, 2013
352013
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population
C Kay, JA Collins, GEB Wright, F Baine, Z Miedzybrodzka, F Aminkeng, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 …, 2018
332018
Characterization of the genetic variation present in CYP3A4 in three South African populations
BI Drögemöller, M Plummer, L Korkie, G Agenbag, A Dunaiski, D Niehaus, ...
Frontiers in Genetics 4, 17, 2013
332013
Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients
M McCormack, H Gui, A Ingason, D Speed, GEB Wright, EJ Zhang, ...
Neurology 90 (4), e332-e341, 2018
312018
Sequencing of GJB2 in Cameroonians and Black South Africans and comparison to 1000 Genomes Project data support need to revise strategy for discovery of nonsyndromic deafness …
J Bosch, JJN Noubiap, C Dandara, N Makubalo, G Wright, JBD Entfellner, ...
Omics: A Journal of Integrative Biology 18 (11), 705-710, 2014
302014
Further investigation of the role of ACYP2 and WFS1 pharmacogenomic variants in the development of cisplatin-induced ototoxicity in testicular cancer patients
BI Drögemöller, B Brooks, C Critchley, JG Monzon, GEB Wright, G Liu, ...
Clinical Cancer Research 24 (8), 1866-1871, 2018
262018
Pharmacogenomics of vincristine‐induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes
GEB Wright, U Amstutz, BI Drögemöller, J Shih, SR Rassekh, MR Hayden, ...
Clinical Pharmacology & Therapeutics 105 (2), 402-410, 2019
242019
Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosis
K Kowalec*, GEB Wright*, BI Drögemöller, F Aminkeng, AP Bhavsar, ...
Nature Genetics 50 (8), 1081, 2018
242018
End of the beginning and public health pharmacogenomics: knowledge in ‘Mode 2’and P5 medicine
V Özdemir, E Fisher, ES Dove, H Burton, GEB Wright, M Masellis, ...
Current Pharmacogenomics and Personalized Medicine 10 (1), 1, 2012
232012
Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS
ABP van Kuilenburg, M Tarailo-Graovac, PA Richmond, BI Drögemöller, ...
New England Journal of Medicine 380 (15), 1433-1441, 2019
222019
The system can't perform the operation now. Try again later.
Articles 1–20